This is the peer reviewed version of the following article: Rusconi, F., et al. (2018). "The Severe Paediatric Asthma Collaborative in Europe (SPACE) ERS Clinical Research Collaboration: enhancing participation of children with asthma in therapeutic trials of new biologics and receptor blockers." European Respiratory Journal 52(4): 1801665., which has been published in final form at DOI: 10.1183/13993003.01665-2018. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived VersionsFunding was received from the European Respiratory Society for this Clinical Research Collaboration. Funding information for this article has been deposited with the Crossref Funder Registry
The European Academy of Allergy and Clinical Immunology (EAACI) organised the first European Strateg...
addresses: Peninsula Technology Assessment Group (PenTAG), Peninsula Medical School, Universities of...
Acknowledgments The authors thank Prof. Stanley Szefler for his comments on the paper and Lisa Law f...
textabstractThe development of new asthma biologics and receptor blockers for the treatment of paedi...
The development of new asthma biologics and receptor blockers for the treatment of paediatric severe...
The development of new asthma biologics and receptor blockers for the treatment of paediatric severe...
New biologics are being continually developed for paediatric asthma, but it is unclear whether there...
The development of new asthma biologics and receptor blockers for the treatment of paediatric severe...
Asthma is one of the most common chronic diseases of childhood. Fortunately, most children with asth...
consensus report Asthma is the leading chronic disease among children in most industrialized countri...
New biologics are being continually developed for paediatric asthma, but it is unclear whether there...
The development of new asthma biologics and receptor blockers for the treatment of paediatric severe...
The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strateg...
Background: The article reviews aims to promote the communication between scientists engaged in bas...
Abstract: Asthma is defined as a chronic inflammatory disorder of the airways with bron-chial hyperr...
The European Academy of Allergy and Clinical Immunology (EAACI) organised the first European Strateg...
addresses: Peninsula Technology Assessment Group (PenTAG), Peninsula Medical School, Universities of...
Acknowledgments The authors thank Prof. Stanley Szefler for his comments on the paper and Lisa Law f...
textabstractThe development of new asthma biologics and receptor blockers for the treatment of paedi...
The development of new asthma biologics and receptor blockers for the treatment of paediatric severe...
The development of new asthma biologics and receptor blockers for the treatment of paediatric severe...
New biologics are being continually developed for paediatric asthma, but it is unclear whether there...
The development of new asthma biologics and receptor blockers for the treatment of paediatric severe...
Asthma is one of the most common chronic diseases of childhood. Fortunately, most children with asth...
consensus report Asthma is the leading chronic disease among children in most industrialized countri...
New biologics are being continually developed for paediatric asthma, but it is unclear whether there...
The development of new asthma biologics and receptor blockers for the treatment of paediatric severe...
The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strateg...
Background: The article reviews aims to promote the communication between scientists engaged in bas...
Abstract: Asthma is defined as a chronic inflammatory disorder of the airways with bron-chial hyperr...
The European Academy of Allergy and Clinical Immunology (EAACI) organised the first European Strateg...
addresses: Peninsula Technology Assessment Group (PenTAG), Peninsula Medical School, Universities of...
Acknowledgments The authors thank Prof. Stanley Szefler for his comments on the paper and Lisa Law f...